Automation Anywhere is a leading provider of robotic process automation (RPA) designed to work side by side with people to handle repetitive routines and tasks. The Company’s automation platform provides bots, powered by AI, trained to automate process steps running on any application. Through Automation Anywhere’s platform, businesses can scale processes faster, with near-zero error rates, while dramatically reducing operational costs. As of December 2020, Automation Anywhere has deployed over 2.6 million bots to support over 3,500 of the world’s largest enterprises, including GM, Cisco, Google, Huawei, FedEx, MasterCard and other world-famous enterprise customers.
Eagle Chip Technology is a leading Chinese FPGA chip developer focusing on the design and R&D of domestic high-end FPGA chips and dedicated EDA tools. The company is committed to breaking through advanced technology of high-end Chinese-making FPGA chips to meet the demand in Chinese market (accounting for 2/3 of global demand by 2025). By creating an open ecosystem for the next generation intelligent, interactive and innovative technology, the company aims to bring industry-leading application solutions to downstream customers across industrial control, telecommunications, consumer electronics, data centers, automotive, artificial intelligence, etc. The R&D team consists of senior personnel from world’s top FPGA developers and academic research experts. Core team members hold 20+ years of experience in FPGA architecture design and EDA tool design, with successful experience in advanced high-end FPGA chip design.
ThoughtSpot is a leading business intelligence analytics platform. It offers large-scale enterprises with search and data analysis driven by artificial intelligence, allowing users to tap into invaluable charts and insights via a simple search query. Through ThoughtSpot, non-technical business decision makers can access deep data analytics without going through complex and cumbersome processes with data scientists and analysts. ThoughtSpot’s analytical service solutions help make decision making up to 85% more efficient compared to other incumbent business intelligence platforms.
Shanghai United Imaging Healthcare Co., Ltd (UIH) is dedicated to providing, developing and producing high-performance advanced medical imaging, radiotherapy equipment, life science instruments and offers intelligent digital solutions to customers worldwide. The advanced medical device and equipment market is usually dominated by international giants, but United Imaging Healthcare breaks this mold and offers numerous products that are #1 in market share in China. Currently, its customers include nearly 900 tertiary hospitals in China, covering all of the top 10 and 49 of the top 50 medical institutions. In August 2022, UIH officially listed on the Science and Technology Innovation Board (STAR Market) of the Shanghai Stock Exchange (SSE: 688271).
23andMe is a leading genetic testing and healthcare company that helps consumers access, understand, and benefit from the human genome. 23andMe offers 3 key products to consumers: “Ancestry Test Kits”, “Ancestry + Genetic Health Test Full Suite Kits” and “23andMe + Total Health”. Through these testing products, customers can receive comprehensive risk assessment reports on their likelihood of developing genetically influenced diseases, including Parkinson’s, Alzheimer’s, Breast Cancer, Ovarian Cancer, Prostate Cancer, diabetes, and a number of other chronic illnesses. Via their Lemonaid Health telehealth platform, they connect patients to licensed healthcare professionals for affordable and direct online medical care. As of October 2023, the Company’s products are offered worldwide, its number of genetic profiles has surpassed 13 million profiles, and is approved to issue more than 55 health reports. 23andMe maintains strategic co-drug development partnerships with large-scale pharmaceutical companies such as GSK. Additionally, 23andMe is currently developing 50 therapeutic programs within its drug pipeline.
Follow Us